1) nanoviricides, armed with virus targeting ligands, can attach and destroy a particular virus among a multitude of viruses (as defined in virus/therapeutic drug pipeline)
2) nanoviricides, armed with several virus strains targeting ligands, can attach to and destroy a multitude of virus strains
The cGMP Pilot Plant is operational and scientists are racing to get it validated. We are also racing (stockpiling) to start the full tox study (GLP) of the FluCide candidate.
Flu Season in Australia is NOT going to wait for us to start, we burn approximately 2M a quarter, therefore if we are racing (no pressure?), progressing in making material in the required quantities, is for one ultimate reason/goal, to file the sponsor applications for human clinical trials internationally, and also an Investigational New Drug application (IND) in the USA. Full Tox study (GLP) 2014 otherwise, why would we be racing?